The patient-related risk factors for periprosthetic joint infection and postoperative mortality in elderly patients undergoing total hip arthroplasty are poorly understood. The purpose of this study was to identify the specific patient comorbidities that are associated with an increased risk of periprosthetic joint infection and of 90-day postoperative mortality in U.S. Medicare patients undergoing total hip arthroplasty.
We identified specific patient comorbidities that were independently associated with an increased risk of periprosthetic joint infection and of 90-day postoperative mortality in Medicare patients who had undergone total hip arthroplasty. This information is important when counseling elderly patients regarding the risks of periprosthetic joint infection and mortality following total hip arthroplasty, as well as for risk adjustment of publicly reported total hip arthroplasty outcomes.
Copyright remains with the authors and publisher.
The patient-related risk factors for periprosthetic joint infection and postoperative mortality in elderly patients undergoing total hip arthroplasty are poorly understood. The purpose of this study was to identify the specific patient comorbidities that are associated with an increased risk of periprosthetic joint infection and of 90-day postoperative mortality in U.S. Medicare patients undergoing total hip arthroplasty.
We identified specific patient comorbidities that were independently associated with an increased risk of periprosthetic joint infection and of 90-day postoperative mortality in Medicare patients who had undergone total hip arthroplasty. This information is important when counseling elderly patients regarding the risks of periprosthetic joint infection and mortality following total hip arthroplasty, as well as for risk adjustment of publicly reported total hip arthroplasty outcomes.
Copyright remains with the authors and publisher.